SOTYKTU is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Deucravacitinib.
Product ID | 0003-0895_ff4d7258-5068-4cdf-9692-8cae04c3198e |
NDC | 0003-0895 |
Product Type | Human Prescription Drug |
Proprietary Name | SOTYKTU |
Generic Name | Deucravacitinib |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2022-09-09 |
Marketing Category | NDA / |
Application Number | NDA214958 |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | DEUCRAVACITINIB |
Active Ingredient Strength | 6 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-09-09 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SOTYKTU 97558218 not registered Live/Pending |
Bristol-Myers Squibb Company 2022-08-22 |
SOTYKTU 97287564 not registered Live/Pending |
Bristol-Myers Squibb Company 2022-02-28 |
SOTYKTU 90718747 not registered Live/Pending |
Bristol-Myers Squibb Company 2021-05-18 |